scholarly article | Q13442814 |
P2093 | author name string | L Bélec | |
M D Kazatchkine | |||
H Adle-Biassette | |||
H Hocini | |||
P Becquart | |||
H Bouhlal | |||
P2860 | cites work | Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase | Q24298754 |
Expression of the secretory leukoprotease inhibitor gene in epithelial cells | Q24617821 | ||
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro | Q28293679 | ||
Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles | Q33782821 | ||
Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues. | Q35764264 | ||
Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus | Q36244894 | ||
HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication | Q36380324 | ||
Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier | Q41143183 | ||
Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor | Q41221414 | ||
A polarized human endometrial cell line that binds and transports polymeric IgA. | Q41365017 | ||
Sexual transmission of HIV. | Q41416566 | ||
Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles | Q41642255 | ||
Mechanism of HIV spread from lymphocytes to epithelia | Q41649409 | ||
Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. | Q41697048 | ||
The elastase-induced expression of secretory leukocyte protease inhibitor is decreased in remodelled airway epithelium | Q42447568 | ||
High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. | Q44620120 | ||
Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I. | Q45758044 | ||
Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription | Q45761404 | ||
Localization and quantitation of a low molecular weight proteinase inhibitor, antileukoprotease, in the human uterus | Q47281030 | ||
Tissue distribution of antileukoprotease and lysozyme in humans. | Q53678454 | ||
Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM | Q59705753 | ||
Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor | Q68856329 | ||
Heterosexual HIV transmission | Q71147389 | ||
P433 | issue | 3 | |
P921 | main subject | transcytosis | Q615386 |
P304 | page(s) | 515-518 | |
P577 | publication date | 2000-05-01 | |
P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
P1476 | title | Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers | |
P478 | volume | 7 |
Q56909607 | A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy |
Q35868058 | Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells |
Q33715960 | Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor |
Q36062918 | Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission |
Q34326489 | Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells |
Q36095139 | Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection |
Q35075174 | Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids |
Q34982574 | Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus |
Q36079848 | Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection |
Q36751036 | Estradiol selectively regulates innate immune function by polarized human uterine epithelial cells in culture |
Q44412688 | Human immunodeficiency virus receptor and coreceptor expression on human uterine epithelial cells: regulation of expression during the menstrual cycle and implications for human immunodeficiency virus infection |
Q30491417 | Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus |
Q33780434 | Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity |
Q44056454 | Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism |
Q34982527 | Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections |
Q24241793 | Interventions for preventing late postnatal mother-to-child transmission of HIV |
Q34046182 | Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys |
Q36862444 | Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex. |
Q28548507 | Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers |
Q39020001 | Purification of a modified form of bovine antithrombin III as an HIV-1 CD8+ T-cell antiviral factor |
Q35153994 | Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens |
Q34474475 | Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys |
Q34775243 | Saliva and inhibition of HIV-1 infection: molecular mechanisms. |
Q37116400 | Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons |
Q37334338 | Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens. |
Q36634965 | Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopes |
Q24598653 | Tenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milk |
Q33874252 | The mouth: a gateway or a trap for HIV? |
Q37290154 | The oral mucosa immune environment and oral transmission of HIV/SIV. |
Q21143809 | The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane |
Q24795604 | Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques |
Search more.